Slimming down the arms presents a challenge for many people on their weight loss journey, but fitness enthusiasts are ...

Keeping Up With the Kardashians' star Khloé Kardashian has been open about her health journey over the years. Here's ...

Patients frequently come to Leslie Golden, MD, with questions about supplements for weight loss. “I’d say nearly every patient has tried or considered supplements at some point before they get ...

Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that’s when a drug is prescribed for something it’s not FDA ...

May lead to loose skin: Significant weight loss, especially rapid or large amounts, can leave behind sagging skin, particularly in the abdomen, arms, or thighs.

DOI: 10.1021/jacs.5c04095 Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population. Despite their effectiveness, they have drawbacks.

Many people also experience rapid weight loss on these drugs, which can lead to the loss of lean muscle. Discuss possible side effects with your doctor to decide which option may be best for you.

Middlesex County Popular ‘miracle’ weight loss drug is causing people to lose their vision, lawsuits claim Published: Jun. 19, 2025, 11:00 a.m.

When Paytas asked the 37-year-old pop star if she's ever experimented with weight-loss drugs, Lizzo replied: "I’ve tried everything. It’s just the science for me: calories in, versus calories out.

Credit: Shutterstock Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite their effectiveness, they have drawbacks.

20 min full body HIIT with no equipment required. For more workouts and programs, check out my app Core by Chloe Ting on the app stores California closes $12 billion budget deficit with hit to ...

More information: Weighted Vest Use or Resistance Exercise to Offset Weight Loss–Associated Bone Loss in Older Adults, JAMA Network Open (2025). DOI: 10.1001/jamanetworkopen.2025.16772 ...